Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
LXRXCompany Name
LEXICON PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLEXICON PHARMACEUTICALS INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LXRX - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 417.91M | $ -120.62M | 0 |
| 3/31/2025 | $ 193.21M | $ -177.3M | 0 |
| 12/31/2024 | $ 141.7M | $ -200.4M | 0 |
| 9/30/2024 | $ 394.03M | $ -216.39M | 0 |
| 6/30/2024 | $ 612.73M | $ -202.11M | 0 |
| 3/31/2024 | $ 418.6M | $ -193.58M | 0 |
| 12/31/2023 | $ 522.02M | $ -177.12M | 0 |
| 9/30/2023 | $ 279.21M | $ -157.86M | 0 |
| 6/30/2023 | $ 458.01M | $ -130.72M | 0 |
| 3/31/2023 | $ 583.85M | $ -110.4M | 0 |
Key Performance Insights, Last 5 Years
- LEXICON PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, LEXICON PHARMACEUTICALS INC's average P/E has been 13.51.
- The median P/E for LEXICON PHARMACEUTICALS INC during this period was 13.51
- LEXICON PHARMACEUTICALS INC reached its highest P/E over the past 5 years at 13.51.
- The lowest P/E recorded by LEXICON PHARMACEUTICALS INC in the same timeframe 13.51
LEXICON PHARMACEUTICALS INC's P/E vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/E Benchmarks
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for LEXICON PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 130.4M ] / Net Inc. Cmn. [ $ -104.22M ]
(=) P/E [ 0 ] LXRX - Price to Earnings, Last 5 years
13.51
Minimum
Jun 30, 2021
13.51
Maximum
Jun 30, 2021
13.51
Average
13.51
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.55 with a standard deviation of 14.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.08K |
|---|---|
| min | 0.13 |
| max | 70.48 |
| average | 22.55 |
| median | 18.89 |
| std | 14 |